Serum hyaluronic acid in critically ill dogs and influence of intravenous fluid therapy
Saved in:
| Main Authors: | Manon Rigot, Alexa M. Bersenas, Shane W. Bateman, Shauna L. Blois, Gabrielle Monteith, R. Darren Wood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165389/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum hyaluronic acid in critically ill dogs and influence of intravenous fluid therapy.
by: Manon Rigot, et al.
Published: (2025-01-01) -
Monitoring of Rivaroxaban Therapy in Hypercoagulable Dogs
by: Erin M. Phillips, et al.
Published: (2025-03-01) -
Principle of intravenous fluid therapy in the neurocritically ill patients
by: Sang-Bae Ko
Published: (2024-12-01) -
Lymphocyte immunophenotype in dogs with immune-mediated hematologic disease.
by: Shauna L Blois, et al.
Published: (2025-01-01) -
Evaluation of the Efficacy of Intravenous Push and Intravenous Piggyback Ceftriaxone in Critically Ill Patients
by: Elly R. Sherman, et al.
Published: (2024-09-01)